Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Anaptysbio (ANAB) over the last 10 years, with Q2 2025 value amounting to $3.5 million.

  • Anaptysbio's Other Non Operating Income changed N/A to $3.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 6070000.0%. This contributed to the annual value of $14000.0 for FY2024, which is 80000.0% up from last year.
  • According to the latest figures from Q2 2025, Anaptysbio's Other Non Operating Income is $3.5 million.
  • Anaptysbio's Other Non Operating Income's 5-year high stood at $3.5 million during Q2 2025, with a 5-year trough of -$5000.0 in Q3 2024.
  • For the 5-year period, Anaptysbio's Other Non Operating Income averaged around $343375.0, with its median value being $3000.0 (2021).
  • As far as peak fluctuations go, Anaptysbio's Other Non Operating Income tumbled by 60000.0% in 2024, and later surged by 9520000.0% in 2025.
  • Anaptysbio's Other Non Operating Income (Quarter) stood at $1000.0 in 2021, then crashed by 500.0% to -$4000.0 in 2022, then skyrocketed by 50.0% to -$2000.0 in 2023, then soared by 1150.0% to $21000.0 in 2024, then surged by 16714.29% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q2 2025, $1.9 million for Q1 2025, and $21000.0 during Q4 2024.